CORRECTED: FTC Pulls Antitrust Probe Over Yasmin Deals
Settlements between Bayer Schering Pharma AG and Barr Laboratories Inc. relating to patent infringement allegations over Bayer's Yasmin birth control drug will no longer be subject to antitrust scrutiny, as the...To view the full article, register now.
Already a subscriber? Click here to view full article